Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124866443 | 12486644 | 3 | F | 201111 | 20160729 | 20160621 | 20160804 | EXP | GB-ABBVIE-11P-167-0886624-00 | ABBVIE | 32.00 | YR | M | Y | 0.00000 | 20160804 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124866443 | 12486644 | 1 | PS | EPILIM | VALPROATE SODIUM | 1 | Intravenous (not otherwise specified) | Y | UNKNOWN | 20593 | 300 | MG | BID | ||||||
| 124866443 | 12486644 | 2 | SS | LEVETIRACETAM. | LEVETIRACETAM | 1 | Unknown | Y | 11I26VM01 | 0 | 250 | MG | BID | ||||||
| 124866443 | 12486644 | 3 | SS | VANCOMYCIN | VANCOMYCIN | 1 | Intravenous (not otherwise specified) | Y | 11I26VM01 | 0 | 1000 | MG | BID | ||||||
| 124866443 | 12486644 | 4 | C | ALFENTANIL. | ALFENTANIL | 1 | 0 | ||||||||||||
| 124866443 | 12486644 | 5 | C | CHLORHEXIDINE | CHLORHEXIDINE | 1 | 0 | ||||||||||||
| 124866443 | 12486644 | 6 | C | DOCUSATE | DOCUSATE | 1 | 0 | ||||||||||||
| 124866443 | 12486644 | 7 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 0 | ||||||||||||
| 124866443 | 12486644 | 8 | C | MAGNESIUM | MAGNESIUM | 1 | 0 | ||||||||||||
| 124866443 | 12486644 | 9 | C | MAGNESIUM SULFATE. | MAGNESIUM SULFATE | 1 | 0 | ||||||||||||
| 124866443 | 12486644 | 10 | C | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | 0 | ||||||||||||
| 124866443 | 12486644 | 11 | C | MIDAZOLAM | MIDAZOLAMMIDAZOLAM HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 124866443 | 12486644 | 12 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 0 | ||||||||||||
| 124866443 | 12486644 | 13 | C | PABRINEX | 2 | 0 | |||||||||||||
| 124866443 | 12486644 | 14 | C | BETAINE | BETAINE | 1 | 0 | ||||||||||||
| 124866443 | 12486644 | 15 | C | PROPOFOL. | PROPOFOL | 1 | 0 | ||||||||||||
| 124866443 | 12486644 | 16 | C | SENNA | SENNA LEAFSENNOSIDESSENNOSIDES A AND B | 1 | 0 | ||||||||||||
| 124866443 | 12486644 | 17 | C | POLYHEXANIDE | 2 | 0 | |||||||||||||
| 124866443 | 12486644 | 18 | C | BETAINE | BETAINE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124866443 | 12486644 | 1 | Product used for unknown indication |
| 124866443 | 12486644 | 2 | Seizure |
| 124866443 | 12486644 | 3 | Product used for unknown indication |
| 124866443 | 12486644 | 4 | Product used for unknown indication |
| 124866443 | 12486644 | 5 | Product used for unknown indication |
| 124866443 | 12486644 | 6 | Product used for unknown indication |
| 124866443 | 12486644 | 7 | Product used for unknown indication |
| 124866443 | 12486644 | 8 | Product used for unknown indication |
| 124866443 | 12486644 | 9 | Product used for unknown indication |
| 124866443 | 12486644 | 10 | Product used for unknown indication |
| 124866443 | 12486644 | 11 | Product used for unknown indication |
| 124866443 | 12486644 | 12 | Product used for unknown indication |
| 124866443 | 12486644 | 13 | Product used for unknown indication |
| 124866443 | 12486644 | 14 | Product used for unknown indication |
| 124866443 | 12486644 | 15 | Product used for unknown indication |
| 124866443 | 12486644 | 16 | Product used for unknown indication |
| 124866443 | 12486644 | 17 | Product used for unknown indication |
| 124866443 | 12486644 | 18 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124866443 | 12486644 | HO |
| 124866443 | 12486644 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124866443 | 12486644 | Drug reaction with eosinophilia and systemic symptoms | |
| 124866443 | 12486644 | Eosinophilia | |
| 124866443 | 12486644 | Hepatitis | |
| 124866443 | 12486644 | Neutropenia | |
| 124866443 | 12486644 | Neutrophilia | |
| 124866443 | 12486644 | Rash erythematous | |
| 124866443 | 12486644 | Renal impairment | |
| 124866443 | 12486644 | Transaminases increased | |
| 124866443 | 12486644 | Tubulointerstitial nephritis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124866443 | 12486644 | 1 | 20111031 | 20111103 | 0 | |
| 124866443 | 12486644 | 2 | 20111103 | 20111103 | 0 | |
| 124866443 | 12486644 | 3 | 201111 | 20111107 | 0 |